15th EUFEPS Talks

We want to invite you to the 15th EUFEPS Talks on February 19, 2024 at 4 pm CET.

Jean-Christophe Leroux will give a talk with the title: "Publication practices: a dangerous drift".

Abstract:

In several scientific disciplines, including pharmaceutical sciences and particularly nanomedicine, there is a growing reproducibility crisis [1]. This crisis has multiple causes and can be partly attributed to the use of increasingly complex experimental protocols and specialized systems, inaccurate or incomplete method descriptions, and a lack of rigor in experimental design [2]. However, another factor that should not be overlooked, which may exacerbate this issue, is the current shift in publication practices. For some research groups, the primary motivation for publishing research findings has moved away from sharing scientific knowledge. Focusing mainly on drug delivery, this presentation will analyze subtle factors contributing to the reproducibility issues in scientific literature and their societal impact. It will also suggest potential solutions for disseminating new knowledge more reliably.

References:

[1]. Leroux JC, Angew. Chem. Int. Ed. 2017, 56, 15170-15171.

[2]. Leroux JC, J Control. Release 2018, 278, 140-141.

CV:

Jean-Christophe Leroux is a full professor of Drug Formulation and Delivery at the Institute of Pharmaceutical Sciences at the ETH Zurich, Switzerland. He has made important fundamental and applied contributions to the fields of biomaterials and drug delivery and has been involved in the development of innovative bio-detoxification systems for the treatment of metabolite disorders. He is a fellow of the AAPS, EURASC, French Academy of Pharmacy, and the CRS, and was the co-founder of the start-up pharmaceutical companies Versantis AG and Inositec AG.

Registration:

A registration is needed for this event. Please use the following link: https://us06web.zoom.us/meeting/register/tZMofu-uqTgqHtZO921bzjWQkM_enKjjakxI. After the registration you will receive an E-Mail with the log-in details.